Rep. Brad R. Wenstrup

Maddy summaryThis bill changes the negotiation period for small-molecule drugs under the federal Drug Price Negotiation Program from 7 years to 11 years, matching the existing 11-year period for biologic drugs. It directly affects drug manufacturers participating in the program by extending the timeframe for price negotiations with the government. The amendment applies to all small-molecule drugs covered under the program, creating a uniform negotiation timeline for both drug types. The change takes effect as if included in the Inflation Reduction Act of 2022.

Maddy summaryHR 7090 would exclude payments and reimbursements for meals, lodging, and travel expenses received by individuals participating in approved clinical trials from their gross income for tax purposes. This directly affects clinical trial participants who currently might have to pay income tax on these compensation amounts. The bill adds a new tax provision (Section 139J) to the Internal Revenue Code, defining "approved clinical trial" per the Public Health Service Act. The change applies to payments made after December 31, 2023.

Maddy summaryThe Strengthening Innovation in Medicare and Medicaid Act (HR 6732) establishes new rules for how the Center for Medicare and Medicaid Innovation (CMI) tests healthcare payment and service delivery models. It limits Phase 1 model testing to 5 years and 500,000 beneficiaries or 10% of applicable individuals, caps new Phase 1 models at six per fiscal year, and requires continuous monitoring of impacts on beneficiaries' access to care and health outcomes. The bill mandates public input through 45-day comment periods before model implementation, hardship waivers for providers facing economic challenges, and special consideration for rural and underserved populations. These provisions aim to balance healthcare innovation with patient protection by requiring ongoing evaluation of models' effects on quality of care, health disparities, and access to services.

Maddy summaryThe Preserving Seniors’ Access to Physicians Act of 2023 increases the Medicare payment adjustment rate for physicians from 1.25% to 4.62%, directly affecting doctors who treat Medicare patients (primarily seniors). It also reduces the funding for the Medicaid improvement fund from $5,796,117,810 to $3,973,117,810. These changes impact Medicare providers and Medicaid programs, with the Medicare adjustment aimed at supporting physicians adjusting to payment changes. The bill does not specify how the Medicaid funding reduction relates to its stated goal of preserving seniors' access to physicians.

Maddy summaryThis bill updates the "competitive need limitation" for duty-free imports from beneficiary developing countries under the Trade Act of 1974. It increases the annual cap for eligible imports from $75 million to $600 million and changes how the limit is calculated to count only duty-free entries during a calendar year. The President must restore duty-free treatment for most eligible articles within 120 days of the bill's enactment, with a one-year review period for sensitive products requiring continued withholding. The bill also requires a report to Congress within one year detailing restored and withheld duty-free treatments. This directly affects importers of goods from designated developing countries eligible for trade benefits.

Maddy summaryThis bill updates Medicare's physician fee schedule to better align with current healthcare costs and support providers. It extends a key deadline for geographic payment adjustments from 2024 to 2025, increases the rate for payment adjustments from 1.25% to 3%, and extends incentive payments for doctors in alternative payment models (APMs) through 2026. For 2026, it imposes payment reductions (34% for 4-6 years in APMs, 67% for 7+ years) but allows exceptions if providers increased their financial risk compared to 2025. The bill also raises Medicare's budget neutrality threshold to $53 million in 2025 and requires regular updates to cost data (like staff wages and equipment prices) every five years. These changes directly affect Medicare-participating physicians, especially those in APMs, by altering payment calculations and incentives.

Maddy summaryHR 6541 directs U.S. Customs and Border Protection to refund duties paid on specific steel and aluminum imports that were retroactively approved for exclusion from additional duties under Section 232 of the Trade Expansion Act. It applies only to steel articles (Harmonized Tariff Schedule 9903.80.01) and aluminum articles (9903.85.01) that received retroactive exclusion approval from the Department of Commerce during 2020-2021. Importers must submit a request within 180 days of the bill’s enactment with details to verify eligibility, and refunds must be issued within 90 days of processing. This bill corrects past overpayments without interest, directly affecting businesses that paid duties on these excluded products.

Maddy summaryThis bill updates Medicare physician payment rules to improve stability and accuracy. It raises the budget neutrality threshold from $20 million (pre-2025) to $53 million in 2025, with annual indexing after 2026, to prevent excessive payment adjustments. The bill requires the Medicare program to correct budget neutrality payments based on actual service utilization data (not estimates) starting in 2025, and mandates updating direct cost inputs (like staff wages and equipment prices) every 5 years. It also caps annual changes to the physician payment conversion factor at 2.5% to limit sudden payment shifts, directly affecting Medicare physicians and healthcare providers receiving these payments.

Maddy summaryThis bill directs the Architect of the Capitol to create a time capsule for the U.S. Semiquincentennial (250th anniversary of independence). Congressional leadership will determine its contents, including representative materials about the Semiquincentennial, copies of key legislative milestones, and a message to future Congress. The capsule will be sealed on the Capitol's West Lawn by July 4, 2026, and remain unopened until July 4, 2276, when it will be presented to the 244th Congress for their consideration. The bill is procedural and does not affect citizens or change existing laws.

Maddy summaryThe Maximum Pressure Act (HR 6114) is a legislative proposal that would maintain and expand U.S. sanctions against Iran. The bill would codify existing sanctions, require Iran to meet 12 specific conditions before sanctions could be lifted (including ending support for terrorism, releasing hostages, and ending nuclear enrichment), and expand sanctions on Iran's Revolutionary Guard Corps and missile programs. It also establishes new reporting requirements for the U.S. government to monitor Iran's activities and the impact of sanctions. The legislation would require congressional review before any sanctions could be lifted or modified, preventing the executive branch from unilaterally easing restrictions.